Home » General World News » A new drug to treat ovarian cancer just got approved (CLVS)

A new drug to treat ovarian cancer just got approved (CLVS)





cancer cells

The FDA just approved a new ovarian cancer drug.

The drug, called Rubraca, is approved to treat women with advanced ovarian cancer who have been treated with two or more chemotherapies and whose tumors have a specific gene mutation. That gene mutation, deleterious BRCA, will have to be identified via a genetic test that the FDA approved Monday.

Clovis Oncology, the drugmaker behind Rubraca, was up as much as 15% following news of the approval.

Rubraca is part of a class of cancer drugs called PARP inhibitors, which block a particular enzyme that’s used by our cells to repair DNA read more >>>

Source:: BusinessInsider.Com

Comments are closed.